R01 CA114004/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2007	1
2008	4
2009	5
2010	4
2011	1
2012	2
2013	2
2014	2
2015	2
2024	0

1

Oncolytic virotherapy reaches adolescence.

Hammill AM, Conner J, Cripe TP. Hammill AM, et al. Pediatr Blood Cancer. 2010 Dec 15;55(7):1253-63. doi: 10.1002/pbc.22724. Epub 2010 Aug 23. Pediatr Blood Cancer. 2010. PMID: 20734404 Review.

2

Targeting cancer-initiating cells with oncolytic viruses.

Cripe TP, Wang PY, Marcato P, Mahller YY, Lee PW. Cripe TP, et al. Mol Ther. 2009 Oct;17(10):1677-82. doi: 10.1038/mt.2009.193. Epub 2009 Aug 11. Mol Ther. 2009. PMID: 19672244 Free PMC article. Review.

3

Going back to class I: MHC and immunotherapies for childhood cancer.

Haworth KB, Leddon JL, Chen CY, Horwitz EM, Mackall CL, Cripe TP. Haworth KB, et al. Pediatr Blood Cancer. 2015 Apr;62(4):571-6. doi: 10.1002/pbc.25359. Epub 2014 Dec 18. Pediatr Blood Cancer. 2015. PMID: 25524394 Free PMC article. Review.

4

Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress.

Kaur B, Chiocca EA, Cripe TP. Kaur B, et al. Curr Pharm Biotechnol. 2012 Jul;13(9):1842-51. doi: 10.2174/138920112800958814. Curr Pharm Biotechnol. 2012. PMID: 21740359 Free PMC article. Review.

5

Adenovirus gene therapy for pediatric cancers: shall we gather at the liver?

Geller JI, Cripe TP. Geller JI, et al. Pediatr Blood Cancer. 2009 Aug;53(2):133-5. doi: 10.1002/pbc.22033. Pediatr Blood Cancer. 2009. PMID: 19353623 Free PMC article. Review. No abstract available.

6

"Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment.

Kaur B, Cripe TP, Chiocca EA. Kaur B, et al. Curr Gene Ther. 2009 Oct;9(5):341-55. doi: 10.2174/156652309789753329. Curr Gene Ther. 2009. PMID: 19860649 Free PMC article. Review.

7

Oncolytic HSV and erlotinib inhibit tumor growth and angiogenesis in a novel malignant peripheral nerve sheath tumor xenograft model.

Mahller YY, Vaikunth SS, Currier MA, Miller SJ, Ripberger MC, Hsu YH, Mehrian-Shai R, Collins MH, Crombleholme TM, Ratner N, Cripe TP. Mahller YY, et al. Mol Ther. 2007 Feb;15(2):279-86. doi: 10.1038/sj.mt.6300038. Mol Ther. 2007. PMID: 17235305 Free article.

8

Phase 1 study of intratumoral Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus, in pediatric cancer patients.

Cripe TP, Ngo MC, Geller JI, Louis CU, Currier MA, Racadio JM, Towbin AJ, Rooney CM, Pelusio A, Moon A, Hwang TH, Burke JM, Bell JC, Kirn DH, Breitbach CJ. Cripe TP, et al. Mol Ther. 2015 Mar;23(3):602-8. doi: 10.1038/mt.2014.243. Epub 2014 Dec 22. Mol Ther. 2015. PMID: 25531693 Free PMC article. Clinical Trial.

9

VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells.

Currier MA, Eshun FK, Sholl A, Chernoguz A, Crawford K, Divanovic S, Boon L, Goins WF, Frischer JS, Collins MH, Leddon JL, Baird WH, Haseley A, Streby KA, Wang PY, Hendrickson BW, Brekken RA, Kaur B, Hildeman D, Cripe TP. Currier MA, et al. Mol Ther. 2013 May;21(5):1014-23. doi: 10.1038/mt.2013.39. Epub 2013 Mar 12. Mol Ther. 2013. PMID: 23481323 Free PMC article.

10

Efficacy and safety of the oncolytic herpes simplex virus rRp450 alone and combined with cyclophosphamide.

Currier MA, Gillespie RA, Sawtell NM, Mahller YY, Stroup G, Collins MH, Kambara H, Chiocca EA, Cripe TP. Currier MA, et al. Mol Ther. 2008 May;16(5):879-85. doi: 10.1038/mt.2008.49. Epub 2008 Mar 25. Mol Ther. 2008. PMID: 18388918 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

19 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year